Admire Dube
@dubelab
Full Professor. Pharmaceutical nanoscience and pharmaceutical regulation. University of the Western Cape
ID: 17646873
https://scholar.google.com/citations?user=_WEW7EkAAAAJ&hl=en 26-11-2008 10:19:22
7,7K Tweet
1,1K Takipçi
677 Takip Edilen
Our combination immunotherapy clinical trial shows that following ART interruption, 4/20 participants controlled HIV without ART for up to 1.5 years. This study sets the stage for more HV cure research in Africa, where the need is greatest HIV Pathogenesis Programme Africa Health Research Institute Science for Africa Foundation
Preparation of thermoresponsive core-corona particles for controlled phagocytosis via surface properties and particle shape transformation. | Akihiko Kikuchi Tokyo University of Science (TUS) | [Open Access] #ShapeChange #photoresponsive #phagocytosis kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…
Check out our co-edited Special Issue of Advanced Therapeutics alongside Admire Dube and Mohammed Balogun (CSIR, South Africa) below 👇 Advanced Therapeutic Technologies for Malaria, Tuberculosis, HIV Infection and Neglected Tropical Diseases advanced.onlinelibrary.wiley.com/toc/23663987/2…
South Africa's innovation fund boosts tech start-ups from universities, driving inclusive economic growth. 🚀💡 theconversation.com/south-african-… 💻 Amy Kahn, HSRC.ac.za #BusinessAndEconomy
Harnessing RGDS peptides to regulate bacterial-host interfaces for targeted antimicrobial therapy. | Jianyong Huang Peking University | [50 days' free access] #peptide #antimicrobial #adjuvant kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…